This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet
Lilly moves to acquire Kelonia, plus gene therapy for deafness approved
04/27/2026
3 min read
News
False
Advertisement
Related Content
Biopharma
Development & Clinical
Interviews
Musings from The Power List: Renee Aguiar-Lucander
September 28, 2026
2 min read
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
Biopharma
Business & Trends
Technology & Manufacturing
The Manufacturing Questions Facing Chinese Biotech
September 9, 2026
5 min read
Lonza’s Wayne Wen discusses the growing maturity of China’s drug development and manufacturing ecosystem – and what companies need to compete internationally
Biopharma
Biopharma
Regulation & Standards
China’s Biopharma Homecoming
September 1, 2026
7 min read
Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han
Biopharma
Biopharma
Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics
August 31, 2026
4 min read
New approaches to oligonucleotide production, mRNA design, and supply chain control could help turn promising nucleic acid therapies into scalable commercial products